Aswan University
Aswān, 81528, Egypt
NCT Number: NCT03767920
Our aim to study the efficacy of bupivacaine 0.25% with dexamethasone and that of bupivacaine 0.25% alone in transversus abdominis plane (TAP) block for postoperative analgesia in patients undergoing an elective Caesarean section.
* Group 1: bupivacaine 0.25% + dexamethasone 8 mg * Group 2: bupivacaine 0.25% A prospective Randomized Interventional double-blind study.
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Not applicable
Aswān, 81528, Egypt
The pain and discomfort following cesarean delivery are mostly due to the abdominal wall incision and dissection of muscles; it delays early ambulation and breastfeeding. This can lead to postoperative complications such as thromboembolic disorders. So, providing an effective and safe postoperative analgesic method seems to be mandatory. Opioid analgesia remains the most effective means of relieving pain in a wide variety of conditions; however, it may cause adverse effects such as nausea, vomiting, pruritus, urinary retention, and respiratory depression. As the analgesia and the side effects of opioids are dose-dependent, a multimodal approach may enhance analgesia, which in turn would decrease the side effects .
Mc Donnell and colleagues have reported that a transversus abdominis plane (TAP) block can decrease the postoperative pain following abdominal surgery. The landmarks of this block were first described in 2001 by Rafi. The TAP block has been performed for postoperative analgesic control in patients undergoing radical prostatectomy, hysterectomy, cesarean delivery under spinal anesthesia, and laparoscopic surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
TAP block with 20 ml of 0.25% bupivacaine bilaterally
Other names: Active Comparator
TAP block with 4 mg dexamethasone bilaterally
Other names: active comparator
TAP block with 4 mg placebo to dexamethasone bilaterally
Other names: Placebo
Time frame: 6 hours post operative
movement-evoked pain measurements ranging from 0 to 10, where 0 no pain and 10 maximum pain
Time frame: 48 hours postoperative
ranging from 0 to 10, where 0 no pain and 10 maximum pain
Time frame: 48 hours postoperative
number of patients need Fentanyl consumption
Time frame: 4 weeks
calculation of number of days patients stay in hospital
Aswan University Hospital
Other
Role of Co-administered Dexamethasone in Transversus Abdominis Plane Block After Cesarean Section: A Randomized, Double-blind Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07720440
Agnosia, Behavior
Istanbul, Sultangazi, Turkey (Türkiye)
View Trial DetailsNCT07720986
Cesarean Section
Al Mansurah, Dakhalia, Egypt
View Trial DetailsNCT07521592
Cesarean Section, Cortisol
Elâzığ, Lütfen Seçiniz., Turkey (Türkiye)
View Trial DetailsNCT07712510
Blood Loss, Postoperative, Blood Loss, Surgical
Multan, Punjab Province, Pakistan
View Trial Details